Navigation Links
Insulet Applauds Employee for Bronze Medal Performance in World Blind Sailing Championships
Date:4/28/2009

Jason Wallenstein Honored by Massachusetts Legislature

BEDFORD, Mass., April 28 /PRNewswire-FirstCall/ -- Insulet Corporation employee, Jason Wallenstein, doesn't let his visual impairment or his diabetes keep him from sailing on a world-class level. Wallenstein and his SailBlind team members from the Carroll Center for the Blind in Newton, MA won the bronze medal in the B3 Division at the 2009 Blind Sailing World Championship Regatta in New Zealand. Wallenstein, who is 34, has Type 1 diabetes and is legally blind, served as the helmsman to steer a Noelex 25, a 25-foot sailboat to the third place victory.

Wallenstein and the SailBlind team were recognized today by both the Massachusetts Senate and the House of Representatives, led by Senator Cynthia Stone Creem and Representative Ruth B. Balser, both of Newton, MA. The SailBlind team was honored for their outstanding performance and ability to serve as an inspiration to other athletes with physical challenges.

"I have been sailing all my life. There was no reason why having Type 1 diabetes and becoming visually impaired later in life would hinder my desire to excel in the sport and compete," said Wallenstein. "I am truly honored to be recognized today by Senator Creem and Representative Balser. I hope that my experiences will demonstrate to others that life's challenges can be turned into opportunities."

Wallenstein works in the product customer service department of Insulet, the leader in tubing-free insulin pump technology with its OmniPod(R) Insulin Management System. "Thanks to the OmniPod, I was able to focus on competing, rather than my diabetes," continued Wallenstein. "As part of the OmniPod product support team, I know firsthand that it is durable enough to withstand the rigors of a world-class sailing competition."

"Jason exemplifies Insulet's mission to make diabetes a smaller part of life. We are inspired by his determination and proud that his accomplishments are being recognized by the Massachusetts State Legislature," said Duane DeSisto, President and Chief Executive Officer of Insulet Corporation.

About the OmniPod Insulin Management System

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod -- a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager -- a wireless, menu-driven, hand-held device that programs the Pod.

About Insulet Corporation

Insulet Corporation (Nasdaq: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contacts:
    Erich Sandoval, Lazar Partners for Insulet Corporation
    Tel. +1-917-497-2867
    E-mail: esandoval@lazarpartners.com


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to ... and other developmental disabilities. The group, which is being launched with the help of ... to share stories and advice, seek help, and continue their education on how to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... announce that we have been designated as a Cigna Infertility Center of Excellence. ... rigorous performance standards. , “It’s an honor to be designated a Cigna ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
Breaking Medicine Technology: